Data From a Phase 2 Nonalcoholic Fatty Liver Disease Trial Looks Promising
luvqs / Pixabay

Data From a Phase 2 Nonalcoholic Fatty Liver Disease Trial Looks Promising

According to a story from tradeshownews.vporoom.com, the biopharmaceutical company Viking Therapeutics, Inc., has recently released the results from a Phase 2 clinical trial. This trial is testing the company's investigational therapeutic…

Continue Reading Data From a Phase 2 Nonalcoholic Fatty Liver Disease Trial Looks Promising
Participants in a Duchenne Muscular Dystrophy Clinical Trial Found out the Drug Wasn’t Working on Social Media
source: pixabay.com

Participants in a Duchenne Muscular Dystrophy Clinical Trial Found out the Drug Wasn’t Working on Social Media

According to a story from nature.com, Amber Sapp's twelve year old son Garrett had been participating in a clinical trial that was testing a new potential treatment for his Duchenne…

Continue Reading Participants in a Duchenne Muscular Dystrophy Clinical Trial Found out the Drug Wasn’t Working on Social Media
Gene Therapy for Fanconi Anemia Gains IND Clearance From the FDA
https://pixabay.com/en/dna-microscopic-cell-gene-helix-1903319/

Gene Therapy for Fanconi Anemia Gains IND Clearance From the FDA

According to a story from BioSpace, the gene therapy company Rocket Pharma recently announced that its investigational product candidate RP-L102 recently saw its Investigational New Drug (IND) application gain approval…

Continue Reading Gene Therapy for Fanconi Anemia Gains IND Clearance From the FDA
Proof of Concept Data Highlights Viability of Gene Therapy for Metachromatic Leukodystrophy
source: pixabay.com

Proof of Concept Data Highlights Viability of Gene Therapy for Metachromatic Leukodystrophy

According to a story from Market Screener, the genetic medicines company Homology Medicines, Inc., recently announced the presentation of data which revealed that the company's proprietary virus vectors, which are…

Continue Reading Proof of Concept Data Highlights Viability of Gene Therapy for Metachromatic Leukodystrophy
This Drug Just Earned Orphan Drug Designation for Pulmonary Alveolar Proteinosis
felixioncool / Pixabay

This Drug Just Earned Orphan Drug Designation for Pulmonary Alveolar Proteinosis

According to a story from BioSpace, the biotechnology company Partner Therapeutics, Inc., recently announced that the US Food and Drug Administration (FDA) has granted Orphan Drug designation to the company's…

Continue Reading This Drug Just Earned Orphan Drug Designation for Pulmonary Alveolar Proteinosis
CAR-T Cell Therapy Earns Regenerative Medicine Advanced Therapy Designation for Multiple Myeloma
source: pixabay.com

CAR-T Cell Therapy Earns Regenerative Medicine Advanced Therapy Designation for Multiple Myeloma

According to a story from Hematology Times, an experimental CAR-T cell therapy called P-BCMA-101 was recently granted regenerative medicine advanced therapy (RMAT) designation from the US Food and Drug Administration.…

Continue Reading CAR-T Cell Therapy Earns Regenerative Medicine Advanced Therapy Designation for Multiple Myeloma
Scientists Identify Abnormal Immune Protein Activity as Trigger for Subcutaneous Panniculitis T Lymphoma
source: pixabay.com

Scientists Identify Abnormal Immune Protein Activity as Trigger for Subcutaneous Panniculitis T Lymphoma

According to a story from Futurity, a recent study has identified a protein that plays a central role in the onset of a rare cancer called subcutaneous panniculitis T lymphoma…

Continue Reading Scientists Identify Abnormal Immune Protein Activity as Trigger for Subcutaneous Panniculitis T Lymphoma
Study Finds That Cystic Fibrosis Patients Aren’t Getting the Treatment They Need to Fight Infection
Myriams-Fotos / Pixabay

Study Finds That Cystic Fibrosis Patients Aren’t Getting the Treatment They Need to Fight Infection

According to a story from EurekAlert!, a recent study from the Children's National Health System has found that some cystic fibrosis patients are not getting sufficient doses of antibiotics in…

Continue Reading Study Finds That Cystic Fibrosis Patients Aren’t Getting the Treatment They Need to Fight Infection

ICYMI: Potential Treatment in the Works for Familial Amyotrophic Lateral Sclerosis

According to a story from telegram.com, a group of researchers from the University of Massachusetts medical school recently announced that they may have reached a major treatment breakthrough for genetically…

Continue Reading ICYMI: Potential Treatment in the Works for Familial Amyotrophic Lateral Sclerosis
Experimental Treatment for NF-1 Gets Orphan Drug Designation
frolicsomepl / Pixabay

Experimental Treatment for NF-1 Gets Orphan Drug Designation

According to a story from BioPortfolio, the biopharmaceutical company SpringWorks Therapeutics recently announced that the US Food and Drug Administration (FDA) has given the company's experimental product PD-0325901 Orphan Drug…

Continue Reading Experimental Treatment for NF-1 Gets Orphan Drug Designation
Rare Blood Cancer Trial Data to be Presented in Upcoming Conference
allinonemovie / Pixabay

Rare Blood Cancer Trial Data to be Presented in Upcoming Conference

According to a story from investors.amgen.com, the drug developer Amgen recently announced its intent to present all new clinical trial data which will feature its latest work in testing a…

Continue Reading Rare Blood Cancer Trial Data to be Presented in Upcoming Conference